Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats
Introduction: Vulvovaginal atrophy (VVA) is a common condition in post-menopausal women. Symptoms of VVA include dyspareunia, vaginal dryness, vaginal and/or vulvar itching, burning and soreness, dysuria and vaginal bleeding accompanying sexual activity. These symptoms are physiological responses to...
Published in: | Frontiers in Endocrinology |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150018020&doi=10.3389%2ffendo.2023.1031066&partnerID=40&md5=ece4dcc3d681967e392dc1e59991932a |
id |
2-s2.0-85150018020 |
---|---|
spelling |
2-s2.0-85150018020 Ismail N.H.; Ibrahim S.F.; Mokhtar M.H.; Yahaya A.; Zulkefli A.F.; Ankasha S.J.; Osman K. Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats 2023 Frontiers in Endocrinology 14 10.3389/fendo.2023.1031066 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150018020&doi=10.3389%2ffendo.2023.1031066&partnerID=40&md5=ece4dcc3d681967e392dc1e59991932a Introduction: Vulvovaginal atrophy (VVA) is a common condition in post-menopausal women. Symptoms of VVA include dyspareunia, vaginal dryness, vaginal and/or vulvar itching, burning and soreness, dysuria and vaginal bleeding accompanying sexual activity. These symptoms are physiological responses to hypoestrogenicity, inducing atrophy of the vagina epithelia and sudden reduction in mucous production. Prevailing therapy for VVA is hormone replacement therapy (HRT), notably estrogen, progesterone or a combination of the two. However, using HRT is associated with an increased incidence of breast and endometrial cancer, venous thromboembolism in the lungs and legs, stroke and cardiovascular complications. Methods: This study evaluated Malaysian Gelam honey as a nutraceutical alternative to estrogen HRT (ERT) in alleviating VVA. A total of 24 female 8-weekold Sprague Dawley rats underwent bilateral oophorectomy. A minimum of 14 days elapsed from the time of surgery and administration of the first dose of Gelam honey to allow the female hormones to subside to a stable baseline and complete recovery from surgery. Vaginal tissues were harvested following a 2-week administration of Gelam honey, the harvested vagina tissue underwent immunohistochemistry (IHC) analysis for protein localization and qPCR for mRNA expression analysis. Results: Results indicated that Gelam honey administration had increased the localization of Aqp1, Aqp5, CFTR and Muc1 proteins in vaginal tissue compared to the menopause group. The effect of Gelam honey on the protein expressions is summarized as Aqp1>CFTR>Aqp5>Muc1. Discussion: Gene expression analysis reveals Gelam honey had no effect on Aqp1 and CFTR genes. Gelam honey had up-regulated Aqp5 gene expression. However, its expression was lower than in the ERT+Ovx group. Additionally, Gelam honey up-regulated Muc1 in the vagina, with an expression level higher than those observed either in the ERT+Ovx or SC groups. Gelam honey exhibits a weak estrogenic effect on the genes and proteins responsible for regulating water in the vaginal tissue (Aqp1, Aqp5 and CFTR). In contrast, Gelam honey exhibits a strong estrogenic ability in influencing gene and protein expression for the sialic acid Muc1. Muc1 is associated with mucous production at the vaginal epithelial layer. In conclusion, the protein and gene expression changes in the vagina by Gelam honey had reduced the occurrence of vaginal atrophy in surgically-induced menopause models. Copyright © 2023 Ismail, Ibrahim, Mokhtar, Yahaya, Zulkefli, Ankasha and Osman. Frontiers Media S.A. 16642392 English Article All Open Access; Gold Open Access |
author |
Ismail N.H.; Ibrahim S.F.; Mokhtar M.H.; Yahaya A.; Zulkefli A.F.; Ankasha S.J.; Osman K. |
spellingShingle |
Ismail N.H.; Ibrahim S.F.; Mokhtar M.H.; Yahaya A.; Zulkefli A.F.; Ankasha S.J.; Osman K. Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
author_facet |
Ismail N.H.; Ibrahim S.F.; Mokhtar M.H.; Yahaya A.; Zulkefli A.F.; Ankasha S.J.; Osman K. |
author_sort |
Ismail N.H.; Ibrahim S.F.; Mokhtar M.H.; Yahaya A.; Zulkefli A.F.; Ankasha S.J.; Osman K. |
title |
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
title_short |
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
title_full |
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
title_fullStr |
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
title_full_unstemmed |
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
title_sort |
Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats |
publishDate |
2023 |
container_title |
Frontiers in Endocrinology |
container_volume |
14 |
container_issue |
|
doi_str_mv |
10.3389/fendo.2023.1031066 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85150018020&doi=10.3389%2ffendo.2023.1031066&partnerID=40&md5=ece4dcc3d681967e392dc1e59991932a |
description |
Introduction: Vulvovaginal atrophy (VVA) is a common condition in post-menopausal women. Symptoms of VVA include dyspareunia, vaginal dryness, vaginal and/or vulvar itching, burning and soreness, dysuria and vaginal bleeding accompanying sexual activity. These symptoms are physiological responses to hypoestrogenicity, inducing atrophy of the vagina epithelia and sudden reduction in mucous production. Prevailing therapy for VVA is hormone replacement therapy (HRT), notably estrogen, progesterone or a combination of the two. However, using HRT is associated with an increased incidence of breast and endometrial cancer, venous thromboembolism in the lungs and legs, stroke and cardiovascular complications. Methods: This study evaluated Malaysian Gelam honey as a nutraceutical alternative to estrogen HRT (ERT) in alleviating VVA. A total of 24 female 8-weekold Sprague Dawley rats underwent bilateral oophorectomy. A minimum of 14 days elapsed from the time of surgery and administration of the first dose of Gelam honey to allow the female hormones to subside to a stable baseline and complete recovery from surgery. Vaginal tissues were harvested following a 2-week administration of Gelam honey, the harvested vagina tissue underwent immunohistochemistry (IHC) analysis for protein localization and qPCR for mRNA expression analysis. Results: Results indicated that Gelam honey administration had increased the localization of Aqp1, Aqp5, CFTR and Muc1 proteins in vaginal tissue compared to the menopause group. The effect of Gelam honey on the protein expressions is summarized as Aqp1>CFTR>Aqp5>Muc1. Discussion: Gene expression analysis reveals Gelam honey had no effect on Aqp1 and CFTR genes. Gelam honey had up-regulated Aqp5 gene expression. However, its expression was lower than in the ERT+Ovx group. Additionally, Gelam honey up-regulated Muc1 in the vagina, with an expression level higher than those observed either in the ERT+Ovx or SC groups. Gelam honey exhibits a weak estrogenic effect on the genes and proteins responsible for regulating water in the vaginal tissue (Aqp1, Aqp5 and CFTR). In contrast, Gelam honey exhibits a strong estrogenic ability in influencing gene and protein expression for the sialic acid Muc1. Muc1 is associated with mucous production at the vaginal epithelial layer. In conclusion, the protein and gene expression changes in the vagina by Gelam honey had reduced the occurrence of vaginal atrophy in surgically-induced menopause models. Copyright © 2023 Ismail, Ibrahim, Mokhtar, Yahaya, Zulkefli, Ankasha and Osman. |
publisher |
Frontiers Media S.A. |
issn |
16642392 |
language |
English |
format |
Article |
accesstype |
All Open Access; Gold Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1812871797479047168 |